Delivery Order SPE2DB22D2206-SPE2DB25FKB77
Award Date 9/24/25
Potential Completion Date 9/25/25
Potential Value $6.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $2,934.36 to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 100-12.5 mg tablets (90-count) on September 16, 2025. This firm fixed price delivery order, with a completion date of September 17, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation. The pharmaceutical product...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Losartan-HCTZ 100-12.5 mg tablets in a 90-count quantity, with a contract ceiling value of $7,054.75. This is a firm fixed price, non-set-aside delivery order with a completion date of September 11, 2025, and performance location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $22,817.18 to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 100-25 mg tablets (90-count) under a firm fixed-price contract. The award was made on August 29, 2025, with an ultimate completion date of September 2, 2025, and the product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Losartan-HCTZ 100-12.5 mg tablets (90-count) valued at $9,377.10. This is a firm fixed price delivery order with no set-aside designation, reflecting competitive procurement for pharmaceutical supplies supporting military and federal healthcare systems. The contract requires completion by September 18, 2025, with performance at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $6,696.51 to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 50-12.5 mg tablets in a 90-count quantity. This firm fixed price delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 24, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency awarded a delivery order valued at $7,415.63 to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 100-25 mg tablets (1,000 units) on September 16, 2025, with an ultimate completion date of September 17, 2025. This non-set-aside contract was awarded under firm fixed-price terms and represents a single delivery order fulfilling pharmaceutical supply requirements for federal medical procurement. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Losartan-HCTZ 100-12.5 mg tablets in a 90-day supply, with a ceiling value of $6,402.24. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award to this qualified pharmaceutical distributor. The contract has an ultimate completion date of September 15, 2025, with performance at AmerisourceBergen's corporate office location...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Losartan-HCTZ 50-12.5 mg tablets in a 90-count quantity. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $28,009.13 and is scheduled for completion by September 10, 2025. The contract represents a single line item fulfillment under AmerisourceBergen's existing pharmaceutical supply vehicle with DLA, with performance to occur...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Losartan-HCTZ 50-12.5 mg tablets in a quantity of 90 units, with a firm fixed price ceiling value of $1,620.32. This is a non-set-aside, competitively awarded contract with an ultimate completion date of September 29, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a delivery order under a larger contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Losartan-HCTZ 100-12.5 mg tablets (90-count) with a ceiling value of $3,567.44. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through competitive procurement. The order is scheduled for completion by September 29, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery...